Labcorp Holdings Inc. 8-K Filing
Ticker: LH · Form: 8-K · Filed: Dec 10, 2025 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Labcorp Holdings Inc. (LH) |
| Form Type | 8-K |
| Filed Date | Dec 10, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Labcorp Holdings Inc. (ticker: LH) to the SEC on Dec 10, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.10 (ange on which registered Common Stock, $0.10 par value LH New York Stock Exchange).
How long is this filing?
Labcorp Holdings Inc.'s 8-K filing is 2 pages with approximately 473 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 473 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-12-10 16:23:26
Key Financial Figures
- $0.10 — ange on which registered Common Stock, $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20251205.htm (8-K) — 27KB
- formpr121025ex991boardmemb.htm (EX-99.1) — 8KB
- lc2020logov2a.gif (GRAPHIC) — 5KB
- 0000920148-25-000120.txt ( ) — 157KB
- lh-20251205.xsd (EX-101.SCH) — 2KB
- lh-20251205_lab.xml (EX-101.LAB) — 22KB
- lh-20251205_pre.xml (EX-101.PRE) — 12KB
- lh-20251205_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On December 10, 2025, the Company issued a press release announcing Dr. Gilliland's retirement from the Board. A copy of that press release is attached to, and incorporated by reference into, this current report as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated December 10 , 2025 issued by the Company Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant Date: December 10, 2025 By: /s/ SANDRA D. VAN DER VAART Sandra D. van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary